IRIS
BELTRAMI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.633
AS - Asia 2.410
EU - Europa 1.898
SA - Sud America 563
AF - Africa 93
OC - Oceania 8
Totale 8.605
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.539
RU - Federazione Russa 740
SG - Singapore 690
CN - Cina 662
BR - Brasile 446
VN - Vietnam 339
IT - Italia 278
HK - Hong Kong 248
GB - Regno Unito 207
IE - Irlanda 130
KR - Corea 128
FR - Francia 119
DE - Germania 103
BD - Bangladesh 97
IN - India 82
SE - Svezia 82
UA - Ucraina 72
FI - Finlandia 67
MX - Messico 45
AR - Argentina 39
IQ - Iraq 30
ZA - Sudafrica 28
CA - Canada 27
NL - Olanda 22
PL - Polonia 22
KE - Kenya 21
TR - Turchia 18
ID - Indonesia 17
CO - Colombia 16
JP - Giappone 16
EC - Ecuador 15
CL - Cile 14
PY - Paraguay 13
SA - Arabia Saudita 13
MA - Marocco 11
VE - Venezuela 10
BE - Belgio 8
ES - Italia 8
IR - Iran 8
PE - Perù 8
PK - Pakistan 8
AU - Australia 7
UZ - Uzbekistan 7
CI - Costa d'Avorio 6
NG - Nigeria 6
TN - Tunisia 6
CZ - Repubblica Ceca 5
LT - Lituania 5
MY - Malesia 5
OM - Oman 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
AT - Austria 3
BB - Barbados 3
BH - Bahrain 3
BW - Botswana 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
NP - Nepal 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
NO - Norvegia 2
RO - Romania 2
RS - Serbia 2
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MR - Mauritania 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 8.605
Salva come PNG Salva come JPEG
Città #
Dallas 1.548
Singapore 399
Moscow 246
Hong Kong 242
Hefei 200
Ashburn 176
San Jose 162
Fairfield 151
Beijing 149
Southend 136
Dublin 129
Seoul 128
Ho Chi Minh City 106
Council Bluffs 86
Los Angeles 79
Ann Arbor 76
Santa Clara 73
Hanoi 72
Woodbridge 71
Houston 69
Seattle 69
Chandler 66
Lauterbourg 66
Jacksonville 55
Wilmington 54
The Dalles 47
Cambridge 43
New York 41
Munich 40
Bengaluru 34
Milan 34
São Paulo 34
Buffalo 32
Dong Ket 27
Orem 26
San Nicola la Strada 26
Siena 24
Turku 24
Helsinki 23
Johannesburg 23
Princeton 23
Rome 23
Düsseldorf 21
Mexico City 21
Chicago 19
Denver 19
Haiphong 19
Redondo Beach 19
Frankfurt am Main 18
Nanjing 17
Warsaw 17
Rio de Janeiro 16
Florence 14
Portsmouth 14
Brasília 13
Chennai 13
San Giuliano Terme 13
Tokyo 13
Baghdad 12
Biên Hòa 12
Brooklyn 12
Da Nang 12
Dearborn 12
Lucca 11
Montreal 11
Shanghai 11
Boardman 10
Columbus 10
Boston 9
Lappeenranta 9
Nairobi 9
Naples 9
New Delhi 9
Phoenix 9
Bari 8
Brussels 8
Guangzhou 8
Tehran 8
Toronto 8
Atlanta 7
Belo Horizonte 7
Bologna 7
Dhaka 7
Lancaster 7
Ninh Bình 7
Porto Alegre 7
San Mateo 7
Abidjan 6
Can Tho 6
Curitiba 6
Goiânia 6
Hebei 6
Quito 6
Riyadh 6
Santiago 6
Tashkent 6
Tianjin 6
Ankara 5
Barnet 5
Bắc Ninh 5
Totale 5.736
Salva come PNG Salva come JPEG
Nome #
The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines 438
Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. 272
Prognostic significance of hyperuricemia in patients with acute heart failure 259
Different trajectories and significance of B-type natriuretic peptide, congestion and acute kidney injury in patients with heart failure 258
Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction 249
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 234
The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer? 227
Patients with cardiorenal syndrome revealed increased neurohormonal activity, tubular and myocardial damage compared to heart failure patients with preserved renal function 226
Variation in Bone Turnover Markers in Professional Sport Players During Training is Mediated by Changes in Sclerostin Levels 221
Neuthrophil gelatinase associated lipocalin better predicts early acute kidney injury and outcome respect to bnp and cystatin c in acute heart failure patients 219
Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application 219
Incidence of stroke in patients with hypertrophic cardiomyopathy implanted with a cardiac implantable electronic device 211
The role of natriuretic peptides for the diagnosis of left ventricular dysfunction 206
Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization 205
Natriuretic peptides and NGAL in heart failure: does a link exist? 203
Current therapeutic strategies in cardiorenal syndrome 191
The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study 186
From gene mutations to biomechanical abnormalities and electrophysiological remodeling in hypertrophic cardiomyopathy: exploring the translational approach. 174
The potential role of natriuretic peptides in acute coronary syndrome stratification 170
Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes 135
Clinical, Laboratory and Lung Ultrasound Assessment of Congestion in Patients with Acute Heart Failure 126
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 117
Additional value of Galectin-3 respect to BNP in acute heart failure patients with preserved ejection fraction 113
Cardiac resynchronization therapy improves functional status and cognition 112
Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF 108
Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure 106
The role of fibrosis, inflammation, and congestion biomarkers for outcome prediction in candidates to cardiac resynchronization therapy: is “response” the right answer? 105
Acute COVID-19 Management in Heart Failure Patients: A Specific Setting Requiring Detailed Inpatient and Outpatient Hospital Care 104
Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting 100
Clinical impact of renal dysfunction in heart failure 98
Cardio-renal syndrome revealed increased neurohormonal activity, tubular and myocardial damage respect to heart failure patients with preserved renal function 93
The predictive value of plasma biomarkers in discharged heart failure patients: the role of plasma BNP 91
Pathophysiological Link and Treatment Implication of Heart Failure and Preserved Ejection Fraction in Patients with Chronic Kidney Disease 90
The Role of the Left Atrium: From Multimodality Imaging to Clinical Practice: A Review 90
Chronotropic incompetence across heart failure categories 89
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 86
Comparison of Demographic, Clinical, Biochemical, and Imaging Findings in Hypertrophic Cardiomyopathy Prognosis: A Network Meta-Analysis 84
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 83
Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update 78
Integrated Cardiorespiratory Rehabilitation and Its Impact on Cardio-Renal-Metabolic Profile After Cardiac Surgery 78
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 77
Relationship between measures of left ventricular systolic and diastolic dysfunction and clinical and biomarker status in patients with hypertrophic cardiomyopathy 75
The relevance of specific heart failure outpatient programs in the COVID era: An appropriate model for every disease 75
Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time 75
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction 74
Relation of QRS Duration to Response to Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block 73
Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence 72
The Different Pathways of Epicardial Adipose Tissue across the Heart Failure Phenotypes: From Pathophysiology to Therapeutic Target 72
Continuous versus intermittent loop diuretics infusion dosing in acute heart failure: effects on renal function, outcome and BNP levels 71
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 71
Relation of QRS duration to response to cardiac resynchronization therapy 70
Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection Fraction: From Clinical Classification to Biomarker Signature 69
Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test—echocardiographic study 66
Coronary microvascular function is impaired in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 63
Different neurohormonal and inflammatory pattern in acute CRS respect to AHF patients with preserved renal function 63
Contemporary assessment of lung ultrasound, BNP and echocardiography for outcome prediction in patients with decompensated heart failure 61
COMPARISON OF DEMOGRAPHIC, CLINICAL, BIOCHEMICAL AND IMAGING AND IMAGING FINDINGS IN HYPERTROPHIC CARDIOMYOPATHY PROGNOSIS: A NETWORK META-ANALYSES 58
Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: An unresolved problem 57
Cost-effectiveness and diagnostic accuracy of focused cardiac ultrasound in the pre-participation screening of athletes: the SPORT-FoCUS study 55
Contemporary assessment of lung ultrasound, bnp and echocardiography predicts outcome in patients with acute heart failure independently to systolic dysfunction 55
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 55
Combination Between Biomarkers and Echocardiographic Data for Prediction of Left Ventricular Reverse Remodelling in Cardiac Resynchronization Therapy 54
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 54
The assessment, interpretation and implementation of lung ultrasound examinations in Heart Failure: Current evidence and gaps in knowledge 53
ATRIOVENTRICULAR BLOCK, AN UNUSUAL CLINICAL PRESENTATION OF CALCIFIED BICUSPID AORTIC VALVE 53
The Role of Multimodality Imaging in Pediatric Cardiomyopathies 52
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 52
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 52
The Role of Lung Ultrasound Scan in Different Heart Failure Scenarios: Current Applications and Lacks of Evidences 51
Comparison of long-term clinical course and outcome of MYBPC3-versus MYH7-related hypertrophic cardiomyopathy 47
Longitudinal function and right ventricular remodeling ratio in acute heart failure: a non invasive measurement of right dysfunction and outcome 47
Transient versus persistent worsening renal function during hospitalization in acute heart failure: different phenotypes for different outcome 43
Cardiac resynchronization therapy improves functional status and cognition at long term follow-up 40
Multi-biomarkers laboratory strategy for outcome prediction in patients with severe systolic dysfunction submitted to CRT 37
Usefulness of contemporary echo and bnp assessment during early hospitalization in patients with acute heart failure 36
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy 32
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study 32
Plasma Neuthrophil Gelatinase associated Lipocalin (NGAL) predict worsening renal function and outcome in patients with acute decompensated heart failure 28
The genetic architecture of left ventricular non-compaction reveals both substantial overlap with other cardiomyopathies and a distinct aetiology in a subset of cases 25
Functional capacity and neurocognitive profile: the effects of cardiac resynchronization therapy 25
Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis 22
Exercise induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test-echocardiographic study 18
Prognostic significance of asymptomatic hyperuricemia and allopurinol therapy in chronic systolic HF outpatients 18
The impact of surgical myectomy on exercise capacity among patients with obstructive hypertrophic cardiomyopathy: Insights from Echo-CPET analysis 18
Left bundle branch area pacing with stylet driven lead in third-degree atrioventricular block following Morrow surgery 16
Eosinophilic granulomatosis with polyangiitis, a new recurrent feature in an extremely rare disease 16
Heart failure and chronic obstructive pulmonary disease. A combination not to be underestimated 16
Ventricular arterial coupling alteration and long term prognosis in patients with hypertrophic cardiomyopathy 14
PLN-related obstructive hypertrophic cardiomyopathy responsive to mavacamten 12
Prevalence of device-detected atrial fibrillation and stroke in patients with hypertrophic cardiomyopathy 11
Incidental cardiac mass: Differential diagnosis, clinical approach and review of the literature,Massa cardiaca incidentale: Diagnosi differenziale, approccio clinico e revisione della letteratura 9
Totale 8.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.436
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/2022162 11 16 9 21 11 9 7 8 6 20 16 28
2022/2023266 16 18 36 30 30 48 6 20 20 6 7 29
2023/2024189 7 4 25 3 4 51 66 7 2 2 1 17
2024/20251.546 11 12 22 15 52 131 159 88 115 116 197 628
2025/20265.653 461 812 1.290 681 871 188 431 121 172 352 270 4
Totale 8.844